Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-22-046017

EVP, Drug Discovery sold 57,743 shares at an average $38.31 ($2,211,978)

  • EVP, Drug Discovery gave up 7,257 shares (to pay taxes)
  • EVP, Drug Discovery acquired 65,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

EMPFIELD JAMES R. · EVP, Drug Discovery

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-12 Exercise or conversion : show line 1 in the form +20,000 $3.10 $62,000 30,000 D
2022-08-12 Exercise or conversion : show line 2 in the form +45,000 $4.75 $213,750 75,000 D
2022-08-12 Shares withheld for taxes : show line 3 in the form −7,257 $38.02 $275,911 67,743 D
2022-08-12 Sale : show line 4 in the form −35,868 $38.08 $1,365,853 31,875 D
2022-08-12 Sale : show line 5 in the form −21,875 $38.68 $846,125 10,000 D
Open-market sales · 57,743 sh · avg $38.31 · $2,211,978

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-08-12 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −20,000 0 D
2022-08-12 Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) −45,000 0 D
Loading xslF345X03/doc4.xml…